UNIVERSITY OF FLORIDA

UNIVERSITY OF FLORIDA logo
🇺🇸United States
Ownership
Private
Established
1853-01-01
Employees
10K
Market Cap
-
Website
http://www.ufl.edu
Clinical Trials
Related News

Photon/Proton Radiation Therapy for Carcinoma of the Nasopharynx

Terminated
Conditions
Nasopharynx Cancer
First Posted Date
2008-11-25
Last Posted Date
2017-02-10
Lead Sponsor
University of Florida
Target Recruit Count
9
Registration Number
NCT00797290
Locations
🇺🇸

University of Florida Proton Therapy Institute, Jacksonville, Florida, United States

Photon/Proton Radiation Therapy for Carcinoma of the Skin of the Head and Neck

First Posted Date
2008-11-25
Last Posted Date
2017-02-07
Lead Sponsor
University of Florida
Target Recruit Count
11
Registration Number
NCT00797043
Locations
🇺🇸

University of Florida Proton Therapy Institute, Jacksonville, Florida, United States

Muscle Composition and Function for Swallowing in Head/Neck Cancer Patients

First Posted Date
2008-11-24
Last Posted Date
2011-09-20
Lead Sponsor
University of Florida
Target Recruit Count
58
Registration Number
NCT00796952
Locations
🇺🇸

University of Florida, Health Science Center, Gainesville, Florida, United States

Proton Radiation for Resectable Carcinoma of the Pancreas

Not Applicable
Completed
Conditions
Pancreatic Cancer
Interventions
Radiation: Proton radiation and chemotherapy
First Posted Date
2008-10-01
Last Posted Date
2017-09-06
Lead Sponsor
University of Florida
Target Recruit Count
8
Registration Number
NCT00763516
Locations
🇺🇸

University of Florida Proton Therapy Institute, Jacksonville, Florida, United States

Lowering Serum Uric Acid to Prevent Acute Kidney Injury

Phase 2
Completed
Conditions
Hyperuricemia
Interventions
Drug: Placebo
Drug: Rasburicase
First Posted Date
2008-09-22
Last Posted Date
2012-09-03
Lead Sponsor
University of Florida
Target Recruit Count
26
Registration Number
NCT00756964
Locations
🇺🇸

University of Florida, Gainesville, Florida, United States

Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores?

Not Applicable
Completed
Conditions
Cancer
Interventions
Other: Karnofsky Performance Status Score
First Posted Date
2008-08-14
Last Posted Date
2013-01-17
Lead Sponsor
University of Florida
Target Recruit Count
200
Registration Number
NCT00735111
Locations
🇺🇸

University of Florida, Gainesville, Florida, United States

Study of Capecitabine to Treat Recurrent High Grade Gliomas

Phase 2
Completed
Conditions
Malignant Glioma
Interventions
Drug: Capecitabine
First Posted Date
2008-07-17
Last Posted Date
2013-07-02
Lead Sponsor
University of Florida
Target Recruit Count
30
Registration Number
NCT00717197
Locations
🇺🇸

University of Florida, Gainesville, Florida, United States

Study of Temozolomide to Treat Newly Diagnosed Brain Metastases

Phase 2
Terminated
Conditions
Brain Metastases
Interventions
Drug: Temozolomide
First Posted Date
2008-07-17
Last Posted Date
2012-10-01
Lead Sponsor
University of Florida
Target Recruit Count
3
Registration Number
NCT00717275
Locations
🇺🇸

University of Florida, Gainesville, Florida, United States

Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma

Phase 2
Withdrawn
Conditions
Primary Central Nervous System Lymphoma
Interventions
Drug: Pemetrexed
First Posted Date
2008-07-09
Last Posted Date
2011-09-20
Lead Sponsor
University of Florida
Registration Number
NCT00712062

Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility

Terminated
Conditions
Candidiasis
HIV Infections
First Posted Date
2008-06-06
Last Posted Date
2015-05-08
Lead Sponsor
University of Florida
Target Recruit Count
10
Registration Number
NCT00692783
Locations
🇺🇸

Duval County Department of Health. Boulevard Comprehensive Care Center, Jacksonville, Florida, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy